1. Home
  2. LMND vs RARE Comparison

LMND vs RARE Comparison

Compare LMND & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMND
  • RARE
  • Stock Information
  • Founded
  • LMND 2015
  • RARE 2010
  • Country
  • LMND United States
  • RARE United States
  • Employees
  • LMND N/A
  • RARE N/A
  • Industry
  • LMND Property-Casualty Insurers
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMND Finance
  • RARE Health Care
  • Exchange
  • LMND Nasdaq
  • RARE Nasdaq
  • Market Cap
  • LMND 2.8B
  • RARE 2.8B
  • IPO Year
  • LMND 2020
  • RARE 2014
  • Fundamental
  • Price
  • LMND $39.98
  • RARE $27.34
  • Analyst Decision
  • LMND Hold
  • RARE Strong Buy
  • Analyst Count
  • LMND 11
  • RARE 15
  • Target Price
  • LMND $32.91
  • RARE $87.40
  • AVG Volume (30 Days)
  • LMND 2.1M
  • RARE 3.1M
  • Earning Date
  • LMND 08-05-2025
  • RARE 08-04-2025
  • Dividend Yield
  • LMND N/A
  • RARE N/A
  • EPS Growth
  • LMND N/A
  • RARE N/A
  • EPS
  • LMND N/A
  • RARE N/A
  • Revenue
  • LMND $558,600,000.00
  • RARE $590,689,000.00
  • Revenue This Year
  • LMND $32.96
  • RARE $18.94
  • Revenue Next Year
  • LMND $43.00
  • RARE $28.61
  • P/E Ratio
  • LMND N/A
  • RARE N/A
  • Revenue Growth
  • LMND 23.12
  • RARE 33.46
  • 52 Week Low
  • LMND $14.90
  • RARE $25.81
  • 52 Week High
  • LMND $53.85
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • LMND 48.63
  • RARE 32.88
  • Support Level
  • LMND $38.64
  • RARE $25.81
  • Resistance Level
  • LMND $43.34
  • RARE $28.52
  • Average True Range (ATR)
  • LMND 2.20
  • RARE 1.66
  • MACD
  • LMND -0.27
  • RARE -0.43
  • Stochastic Oscillator
  • LMND 33.89
  • RARE 9.24

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: